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Introduction. Preoperative malnutrition is a major risk factor for increased postoperative morbidity and mortality. Deﬁnition and
diagnosis of malnutrition and its treatment is still subject for controversy. Furthermore, practical implementation of nutrition-
related guidelines is unknown. Methods. A review of the available literature and of current guidelines on perioperative nutrition
was conducted. We focused on nutritional screening and perioperative nutrition in patients undergoing digestive surgery, and
we assessed translation of recent guidelines in clinical practice. Results and Conclusions. Malnutrition is a well-recognized risk
factor for poor postoperative outcome. The prevalence of malnutrition depends largely on its deﬁnition; about 40% of patients
undergoingmajorsurgeryfulﬁl currentdiagnosticcriteriaofbeingatnutritionalrisk.TheNutritional Risk Scoreisapragmaticand
validated tool to identify patients who should beneﬁt from nutritional support. Adequate nutritional intervention entails reduced
(infectious) complications, hospital stay, and costs. Preoperative oral supplementation of a minimum of ﬁve days is preferable;
dependingonthepatientandthetype ofsurgery,immune-enhancingformulasarerecommended.However,surgeons’compliance
with evidence-based guidelines remains poor and eﬀorts are necessary to implement routine nutritional screening and nutritional
support.
1.Introduction
The World Health Organization cites malnutrition as the
greatest single threat to the world’s public health. Indeed,
thereported in-hospital prevalenceofmalnourished patients
on admission ranges up to 50% [1–5]. Increasing evidence
has been accumulated during recent years that nutritional
screeningandtherapyareimportantadjunctsinmodernsur-
gical care since up to 40% of patients are at nutritional risk
preoperatively [6–8]. Malnutrition before gastrointestinal
(GI) surgery is caused by decreased oral food intake, preex-
istingchronicdisease, tumourcachexia,impaired absorption
due to intestinal obstruction, and previous surgical bowel
resection. Moreover, low socioeconomical status, as often
seen in elderly and handicapped patients, represents an addi-
tional risk factor [7, 9].
Malnourished patients have a signiﬁcantly higher mor-
bidity and mortality, a longerl e n g t ho fs t a y( L O S )a n d
increased hospital costs [1, 6, 7, 10, 11]. Perioperative
nutrition has been convincingly shown to improve clinical
outcome in patients undergoing major GI surgery and to
reduce costs [1, 12]. The mechanism of action seems to be
notonlyanimprovednutritionalstatusbyprovidingahigher
caloric intake, but primarily a reenforced immune response;
nutritional formulas containing immune-modulating agents
(glutamine, arginine, n-3 fatty acids, and ribonucleic acids)
are particularly beneﬁcial modulators of the acute stress
response [13, 14]. Various original studies and compre-
hensive guidelines have been issued recently to deﬁne pre-
operative screening and to standardize perioperative nutri-
tion with regard to mode, timing, duration, and formula
[15]. Furthermore, there are only scarce data assessing the2 Gastroenterology Research and Practice
practical implementation of these evidence-based recom-
mendations.
The aim of this study was to assess the current evidence
for nutritional screening as well as perioperative nutrition in
major abdominal surgery and its implementation in daily
clinicalpractice.Furthermore,apragmaticalgorithmforevi-
dence-based perioperative nutrition is provided.
2.Methods
2.1.DataSourcesandSearchStrategies. Relevantarticles were
identiﬁed searching Medline (through PubMed) by use of
the appropriate MeSH terms for the following search items:
malnutrition, nutritional screening, nutritional risk, peri-
operative (pre-, postoperative) nutrition (oral, enteral, and
parenteral), immunonutrition, practical implementation of
nutritionalscreening, andsupportingANDmajorGIsurgery
AND clinical outcome (complications, mortality, andhospi-
tal stay). Hand-searched electronic links and references of
selected articles were cross-checked. The search was limited
to studies published between January 1980 and June 2010
as no frequently cited milestone articles on perioperative
nutritionhavebeenpublishedbefore.Onlyarticlespublished
in English were considered eligible [16].
2.2. Study Selection. We privileged systematic reviews and
meta-analyses from high-impact peer-reviewed journals
and recent evidence-based guidelines. Further, important
original studies adding complementary information were
included. Selected studies had to treat the clinical impact of
either (i) malnutrition, or (ii) nutritional screening (iii), or
perioperative nutrition, or (iv) the practical implementation
of nutritional screening and support in digestive surgery.F o r
each of these areas, two authors independently performed
the literature search; studies of interest were identiﬁed by
screening of title, abstract, or medical subject headings. Final
decisionon inclusionwas made based on the full text articles
by the entire research team.
3.Results
The electronic search of the literature identiﬁed more than
a thousand possible hits. These were carefully screened, and
irrelevant studies were excluded by title, abstract, or full
text analysis. Covering a large thematic array, many eligible
studies fulﬁlled the inclusion criteria. Therefore, a further
selection was necessary based on quality and importance
for our aims. Finally, we included 68 publications, of those,
14 reviews/guidelines and 36 randomized controlled trials
have been identiﬁed as major contributions to the ﬁeld of
perioperative nutrition.
3.1. Deﬁnition and Diagnosis of Malnutrition. Since there
are no standardized and widely accepted deﬁnitions, precise
diagnosis of malnutrition remains diﬃcult. This major
methodological shortcoming contributes to the heterogene-
ity of studies and also impairs proper assessment of mal-
nutrition in daily clinical practice. Diagnostic criteria range
from simple patient’s data, such as amount of food intake,
weight loss[18],orbody mass index, tobiochemical markers
(albumin [19], prealbumin [20]) or various physiologic
assessments. In order to develop simple, reliable, and repro-
ducible screening tools, these parameter are often combined
in scores (i.e., nutritional risk index (NRI) [21]) to grade
the severity of malnutrition. Questionnaires such as the
subjective global assessment (SGA) [22] are also described.
Biometricalanalyses,suchasthephaseangle(PA)[23]whic h
quantiﬁesbodyleanmassandfatbyelectricalimpedance,are
less frequently used (Table 2).
The most valuable tool for nutritional screening for sur-
gical patients is currently the Nutritional Risk Score (NRS)
that is oﬃcially recommended by the European Society of
Parenteral and Enteral Nutrition (ESPEN) [17]. It is based
on the amount of malnutrition, as deﬁned by weight loss,
food intake, and BMI, as well as on the severity of disease
(Table 1). Its predictive value was validated by applying it
to a retrospectively 128 RCTs on nutritional support [17]
and prospectively in a cohort including 5051 hospitalized
patients in 12 European Countries and 26 diﬀerent surgical
centers [8]. The NRS used retrospectively was able to
distinguish between trials with a positive eﬀect of perioper-
ative nutritional support versus those with no eﬀect. When
applied prospectively, it showed that “at-risk” patients had
more complications, higher mortality, and longer lengths
of stay than “not-at-risk” patients, and these variables
were signiﬁcantly related to components of NRS-2002, also
when adjusted for confounders. The prevalence reported of
patients at risk evaluated by NRS varies in literature from 14
to 32.6% [7, 8, 24].
Since the objective in diagnosing malnutrition is to treat
it as early as possible in order to improve patient’s outcome,
screening tools have to be correlated to postoperative
outcome. In the comparison of Antoun et al., who evalu-
ated several screening system, only serum albumin <30g/L
showed a signiﬁcant association to postoperative morbidity
after multivariate analysis [19]. Schiesser et al. undertook a
comparison between the NRS, NRI, and PA. These methods
were well correlated fordiagnosis ofmalnutrition. Moreover,
they had a predictive value for postoperative complications.
The strongest correlation for the diagnosis of malnutrition
was found between NRS and NRI, but only NRS was able
to reliably predict postoperative morbidity after multiple
regression analysis [23].
3.2. Treatmentof Malnutrition. Perioperativemalnutrition is
considered as a modiﬁable and treatable cause of postopera-
tive morbidity[25, 26]. While nutritional support has shown
to reduce infections, complications, LOS, and costs [27–29],
many questionsremain concerning patient selection, timing,
route of administration, and type of nutritional support
remains to be elucidated.
3.2.1. Patient Selection. Patients are considered to be at
severe nutritional risk if the NRS is ≥3o ri fa tl e a s to n e
of the following criteria is fulﬁlled: weight loss of 10–
15% within 6 months, BMI < 18.5kg/m2, Subjective GlobalGastroenterology Research and Practice 3
Table 1: Nutritional Risk Screening score (NRS 2002) [17]. The total score is obtained by adding the nutritional score to the disease score.
Age > 70 years adds 1 to the total score. If age-corrected total is ≥3, the patient presents severe malnutrition, and nutritional support is
recommended.
Malnutrition Mild Moderate Severe
Score 1 Score 2 Score 3
Nutritional
Status
BMI (kg/m2) — 18.5–20.5 <18.5
Food Intake (%) 50–70 25–50 <25
Weight loss <5 % 3m o n t h s 2m o n t h s 1m o n t h
Disease
severity Example Hip fracture, cirrhosis,
COPD Major surgerya,S t r o k e
Head injury, bone marrow
transplantation,ICU
patients (APACHE 20)
Age (Years) >70
aMajor abdominal surgery includes colorectal, gastric, liver, pancreatic, and esophageal resection for benign and malignant disease by either laparotomy or
laparoscopic approach, lasting usually>2h.
Table 2: Overview on common screening tools for malnutrition and its reported prevalence depending on study and screening tool.
Antoun et al. Schiesser et al.
Malnutrition Weight loss BMI (kg/m2)S G AAlbumin
(g/L) NRI NRS (2002)∗∗ PA NRI
None — (29%)1 18.5–25(50%)1 A (66%)1 >35 >97.5(59%)1 Score 0 >6◦ (71%)2 >97.5(85%)2
Mild <10%(39%)1 <18.5 (8%)1
B (22%)1 <35 (24%)1 84–97.5
(32%)1
Score 1 (89%)2
<6◦ (28%)2 84–97.5
(13%)2 Moderate Score 2 (8.5%)2
Severe ≥10% (20.5%)1 <16 (2%)1 C (12%)1 <30 (8%)1 <84 (9%)1 Score 3 (2.5%)2 <84 (2%)2
BMI: body mas index (kg/m2); SGA: subjective global assessment (weight, food intake, symptoms, and activities); NRI: nutritional risk index (recent weight
loss, serum albumin); NRS (2002): nutritionalrisk screening score (Table 2); PA: phase angle (reactance and resistance from bioimpedance analysis).
1Antoun et al. [18] (prevalence %).
2Schiesseret al. [23] (prevalence %).
∗∗Nutrition statusscore only.
Assessment Grade C or Serum albumin <30g/L [26, 30].
For these patients, major surgery should be postponed until
nutritional status has been corrected [26].
Most patients with GI cancer have severe malnutrition
preoperatively and their immunological function is sup-
pressed. Moreover, prolonged postoperative fasting and in-
suﬃcient oral food intake may worsen preexisting malnu-
trition. Hence, there is an increased risk of postoperative
complication, and all patients should therefore beneﬁt from
perioperative nutrition prior to major oncological surgery
[29].
Whenthe NRSisused, patients, with a score of3ormore
arepronetodeveloppostoperativecomplicationsandshould
beneﬁt from nutritional support [8, 23]. Since age directly
inﬂuences the NRS [15], elderly patients (>70 years) must
be considered as at particular risk [8]. Nutritional proﬁle
of these patients is a good prognostic factor and eﬀorts
should be made to maintain an optimal nutritional status
[31].
It has been shown that even in wellnourished patients,
peripoperative nutritional support positively inﬂuences
postoperative outcome [25]. Enhanced recovery programs
have developed for such patients, with a particular focus to
minimizing preoperative fasting period and maximizing
carbohydrate loading [32].
3.2.2. Timing of Nutrition. The role of preoperative nutri-
tional support is to improve undernutrition before surgery,
while postoperative nutrition aims at maintaining nutri-
tional status in the catabolic period after surgery. The timing
of nutritional support is widely debated. While conventional
enteral nutritional support is recommended for 10–14 days
prior to major surgery in patients with severe nutritional
risk to improve the nutritional state, immunonutrition (IN)
is administered for 5–7 days prior to surgery to all cancer
patients in order to improve immune function [26].
Although preoperative fasting has long been considered
as a dogma, Brady et al. showed that a 2-hour fasting for
clear ﬂuids does not increase complications [33]. Nowadays,
a preoperative fasting of 2hours for ﬂuids and 6hours for
solid food is considered as best practice and recommended
by the ERAS(Enhanced RecoveryAfter Surgery) group [32].
Postoperatively, normal oral food intake or nutrition
through feeding tube should start within the ﬁrst 24hours.
A recent meta-analysis evaluated early commencement of4 Gastroenterology Research and Practice
postoperative enteral nutrition (within 24h) versus tradi-
tional management in patients undergoing gastrointestinal
surgery. It was in favour of early enteral feeding following
gastrointestinal surgery to reduce morbidity and mortality
rates [34, 35]. The beneﬁcial eﬀect of early oral feeding was
also shown by El Nakeeb et al. [36]. There is strong evidence
that oral nutritional supplements (200mL twice daily) given
from the day of surgery until normal food intake is achieved
are beneﬁcial.
While perioperative nutritional support is recommend-
ed, some studies suggest that nutrition limited to the pre-
operative phase might have the same beneﬁcial eﬀects than
combined pre- and postoperative nutrition. As far as IN is
concerned, three RCTs have found no diﬀerence when com-
paring pre- and perioperative IN patients [13, 18, 25].
Another study compared IN given perioperatively with con-
trol patients receiving IN only postoperatively [37]. A signif-
icant decrease in postoperative complications is seen in the
perioperative IN group compared to the postoperative IN
group.
The optimal duration of nutritional support in the post-
operative period remains unclear. While using postoperative
oral nutritional supplements for 8 weeks in malnourished
patients enhances recovery of nutritional status and quality
of life [38], beneﬁts for well-nourished patients are less
evident [39]. Concerning postoperative IN, duration of
therapy varied from 3 [40]t om o r et h a n1 0d a y s[ 18, 25, 41–
45], with the most common duration being 7 days [13, 46–
51].
3.2.3.RouteofAdministration. Basically, nutritional support,
with or without regular oral diet, can be administered in
three ways: orally as oral nutritional supplements (ONSs),
enterally through a feeding tube, or parenterally. As stated
in the ESPEN 2006 guidelines, the enteral route should
always be preferred bar if intestinal obstruction, severe shock
or intestinal ischemia is present. Stratton and Elia showed
that both oral nutritional supplements (ONSs) and feeding
tube nutrition (FTN) were able to reduce postoperative
complicationsingastrointestinal (GI)surgicalpatients,when
compared to routine care nutrition alone. However they had
no inﬂuence on mortality [27]. When FTN was compared to
parenteral nutrition in cancer patients undergoing surgery,
those receiving enteral nutritional support had signiﬁcantly
less infectious complications.
Lassen et al. studied the postoperative outcome of
patients undergoing major upper GI surgery. Those allowed
to eat at will had less complications and shorter hospital
stay than patients fed through a needle-catheter jejunostomy
[52].
3.2.4. Type of Supplementation. A whole variety of nutri-
tional supplementationwas identiﬁed through the electronic
database search.
There is strong evidence that clear carbohydrate-rich
beverage administration before midnight and 2 to 3hours
before colonic surgery ameliorates pre- and postoperative
patient’s status, accelerates, recovery and shortens hospital
stay [32].
Immunonutrition, which contains a combination of glu-
tamine, arginine, n-3 fatty acids, and RNA, has been eval-
uated in numerous studies [13, 25, 29, 41, 43, 46, 47, 50,
51, 53, 54]. A recent meta-analysis assessed the impact of
IN on postoperative complications, in particular infectious
complications, length of hospital, stay and mortality in
patients undergoing major GI surgery. Twenty-one RCTs
enrolling a total of 2730 patients were included in the
meta-analysis. IN signiﬁcantly reducedoverallcomplications
when used preoperatively, perioperative, or postoperatively.
Patients receiving IN had less infection. The mean diﬀerence
in LOS favoured IN (−2.12 (95% CI −2.97, −1.26) days).
However, perioperative IN had no inﬂuence on mortality
(submitteddata).In allofthe9RCTsevaluatingpreoperative
IN, duration of supplementation was within the 5–7 days
recommended range [13, 18, 25, 29, 40, 46, 55–57].
When each component of IN was studied separately,
disparity was observed in the results.
Jiang et al. compared cancer patients receiving omega
3 supplementation postoperatively for 7 days to patients
receiving an isocaloric isonitrogenous diet. They found a
lower incidence of infectious complications and a shorter
lengthofstayinthetreatmentgroup.However,nosigniﬁcant
diﬀerence could be demonstrated as far as costs are con-
cerned [58]. A meta-analysis showed a decrease in infection
rate, but no advantage in LOS or mortality [59].
While Sun et al. demonstrated that branched chain
amino acid enriched total parenteral nutrition reduced post-
operative complications in malnourished patients with gas-
trointestinal cancer undergoing major surgery [60], Gianotti
et al. failed to improve the clinical outcome of patients
receiving perioperative amino acids [61]. In another RCT,
parenteral glutamine supplementation in the preoperative
period failed to decrease infection rate, wound complication,
days in the intensive care unit, and mortality [62].
3.3. Implementation of Current Guidelines in Clinical Practice.
Implementation of nutritional support strategies into daily
clinical practice encounters many diﬃculties and consider-
able eﬀorts are needed to be successful. It has been shown
in several studies that malnutrition is either not recognized
or not viewed as clinically signiﬁcant and that appropriate
interventions are not considered necessary [3, 11].
Arecent one-day multinational cross-sectional European
audit showed that instruments used to identify undernour-
ished patients and those at risk diﬀer widely. Often, national
and validated tools are replaced with locally developed
ones. Many countries do not implement the recommended
screening policy, which leads to underdiagnosis and under-
treatment of malnutrition [63].
Our group conducted a survey among Swiss and Aus-
trian public hospitals in order to get information about
implementation of the above-mentioned current guidelines.
We inquired about nutritional screening and therapy and
appraisal of current evidence of perioperative nutritional
support.
Conforming to previous data, we observed that imple-
mentation of current guidelines was modest at best. Only
20% of the participating centres routinely screened theirGastroenterology Research and Practice 5
Postpone surgery
oral/enteral nutrition
2 weeks pre-op
5–7days pre-op:
Immunonutrition
5–7days
pre-op:
SEN
5–7days
pre-op:
IN
Surgery within enhanced recovery protocols if available
consider placement of percutaneous or nasoenteral nutritionalcathetersif
A prolonged postoperative fasting or
B insuﬃcient food intake probable
Severe
malnutrition?
1
2
3
+
+
+ +
−
−
−
−
4
∗
Routine nutritional screening by use of the NRS
if severe malnutrition is suspected: additional clinical and laboratory parameters
Early post-op food intake within
enhanced recovery protocols if
available, consider oral supplements
Consider preferentially enteral or if
contraindicatedf parenteral nutrition until
suﬃcient food intake is assured
High probability of
A prolonged postoperative fasting or
B insuﬃcient food intake ?c
NRS ≥ 3?
3×
No!
Major upper GI
cancer surgery?b
All patients before major abdominal surgerya
Figure1:Pragmaticalgorithmforpreoperative nutritionalscreeningandperioperativenutritionindigestivesurgery. Thealgorithmresumes
perioperative care in terms of nutrition in major abdominal surgery. It is largely based on recent systematic reviews and guidelines on
perioperative nutrition [26, 27] and enhanced recovery [32]. aMajor abdominal surgery includes colorectal, gastric, liver, pancreatic, and
esophageal resection for benign and malignant disease by either laparotomy or laparoscopic approach, lasting usually >2h. bMajor upper
GI surgery indicating preoperative IN regardless of nutritional status include oesophageal, gastric and pancreatic resection for cancer [26].
cdeﬁned as anticipated perioperative starving >7d a y sa n do r a li n t a k e<60% of recommended for >10 days [26]. NRS: Nutritional Risk
Score; pre-OP: pre-operative, IN: immunonutrition, SEN: standard enteral nutrition (usually whole protein formula). ∗currently evaluated
by (http://www.clinicaltrial.gov; trial # NCT005122).
GI surgery patients for nutritional status. Great disparities
existed regarding screening methods. Approximately two
thirds of centres were using various combinations of clinical
and laboratory parameters to assess patients’ nutritional
status.Inourstudy,theNRSwasonlyusedby14%ofcentres.
Nutritional treatment was part of perioperative care in
about 70% of all centres, and mostly dedicated to cancer
patients or patients undergoing major surgery rather than to
patients previously screened for their nutritional risk.
Overall, about two thirds of all centres estimated that
there is enough scientiﬁc evidence in favour of preoper-
ative nutritional support. Reduced complication rates and
decreasedlengthofhospitalstaywereacknowledgedasmajor
advantages. Logistic and ﬁnancial issues were mentioned as
reasons against the implementationof nutritional support in
daily clinical practice (submitted data).
4.Discussion
The present paper summarizes the current evidence on pre-
operative nutritional screening and perioperative nutrition
in major abdominal surgery. Malnutrition is a common
problem in GI surgery patients (40%) and doubtlessly one
of the most important risk factors for postoperative compli-
cations. The NRS is a validated screening tool that reliably
identiﬁes patients at nutritional risk who beneﬁt from a
nutritional supplementation. Recent high-quality studies6 Gastroenterology Research and Practice
have delivered convincing evidence that perioperative nutri-
tion is a highly eﬀective treatment that entails reduced com-
plications, hospital stay, and costs. Most impressive results
have been obtained by preoperative administration of im-
munonutrition.
The recent data permitted to issue actual evidence-
based guidelines in an attempt to standardize perioperative
nutrition in abdominal surgery. We outlined, however, that
implementation of these recommendations is not satisfac-
tory.
In a recent survey (unpublished data), most responding
surgeons acknowledged clearly the positive impact of peri-
operative nutrition on postoperative outcome. Nevertheless,
cost issues for outpatient nutrition and time restraints are
obviously prominent reasons against nutritional care. The
formation of specialized multidisciplinary teams failed to
improve nutritional care. It can be therefore assumed that
the individual surgeon is the most straightforward way to
increase adherence to nutritional guidelines!
Based on the current literature and guidelines, we pro-
pose a simple and pragmatic algorithm for preoperative
nutritional screening and perioperative nutritional therapy
(Figure 1). All patients undergoing major surgery should
be screened for malnutrition. Depending on the degree of
malnutrition and the type of surgery, nutritional support
should start within 14–7 days preoperatively. If insuﬃcient
postoperative food intake is anticipated, early enteral tube
feeding should be started.
In conclusion, malnutrition is a well-known major risk
factor for poor postoperative outcome. Preoperative nutri-
tional screening is therefore mandatory to identify patients
who need perioperative nutritional support. For most
patients, a preoperative oral supplementation by whole pro-
tein formulas or immunonutrition is suﬃcient. The proven
beneﬁts for the patients justify the considerable eﬀorts to fo-
ster implementation of these current guidelines in clinical
practice.
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